Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4) Article

International Collaboration

cited authors

  • Cornelissen, Robin; Prelaj, Arsela; Sun, Sophie; Baik, Christina; Wollner, Mirjana; Haura, Eric B.; Mamdani, Hirva; Riess, Jonathan W.; Cappuzzo, Federico; Garassino, Marina C.; Heymach, John V.; Socinski, Mark A.; Leu, Szu-Yun; Bhat, Gajanan; Lebel, Francois; Le, Xiuning; Zenith20 4 Invest

authors

Publication Date

  • August 1, 2023

webpage

published in

category

start page

  • 1031

end page

  • 1041

volume

  • 18

issue

  • 8